Top Industry Leaders in the Neuroprosthetics Market
Latest Neuroprosthetics Companies Updates:
Abbott Laboratories Received CE mark approval for their FreeStyle Libre 3 sensor system, offering longer wear time and improved accuracy for continuous glucose monitoring (CGM).Focusing on expanding access to CGM technology and competing with traditional blood glucose meters through competitive pricing and reimbursement deals.
Medtronic Received FDA approval for their Intellineure Deep Brain Stimulation (DBS) System, featuring advanced algorithms and closed-loop stimulation capabilities for Parkinson's disease treatment.Collaborating with research institutions on developing next-generation DBS technologies for treating various neurological disorders.
Neuralink Elon Musk's company revealed advancements in their Brain-Computer Interface (BCI) technology, showcasing potential for restoring vision and controlling robotic limbs.Facing ethical and regulatory hurdles, but their progress continues to generate significant interest in BCI applications.
Synchron Received FDA Breakthrough Device Designation for their Stentrode BCI system, designed to restore communication and mobility for paralyzed individuals.Partnering with medical centers to initiate clinical trials and advance their innovative BCI technology towards patient use.
Other Players Companies like Boston Scientific, Paradromic Technologies, and Blackrock Neurotech are also contributing to market growth with diverse neuroprosthetics solutions for various neurological conditions.
List of Neuroprosthetics Key companies in the market
- Medtronic (US),
- Abbott (US),
- Cochlear (Australia),
- Boston Scientific (US),
- Livanova (UK),
- Second Sight (US),
- Med-El (UK),
- Retina Implant (US),
- Sonova (UK),
- Neuropace (US),
- Nevro (California)
